Full Text
Defining Value When Launching Biosimilars Treatments Within European Healthcare Systems

Abstract

Authors

R White O Staples

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×